Application 216608
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARIPIPRAZOLE | ARIPIPRAZOLE | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 300MG/VIAL | No | No |
| 002 | ARIPIPRAZOLE | ARIPIPRAZOLE | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 400MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216608-001 | ARIPIPRAZOLE | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | ||
| A216608-002 | ARIPIPRAZOLE | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-002 | AP | 1 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | 96172aa4-9e13-4eca-83d5-85a88c1782d3 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| ARIPIPRAZOLE | ARIPIPRAZOLE | A-S Medication Solutions | db6fc74e-4989-464d-9c19-a5b7a541fd46 | 2024-03-10 | Boxed warning, Warnings, Adverse reactions | ARIPIPRAZOLE ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Camber Pharmaceuticals, Inc. | 2d8d574b-fbf4-4d2c-a37c-25556ecbf1aa | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | fd2fa4da-2ee9-4965-b1f8-ce1c8b73ba93 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Proficient Rx LP | fbd81df7-8482-493e-bfc5-a3352f466b9e | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | NorthStar RxLLC | f87dbfe4-5417-47c9-a97f-d246cfc10023 | 2023-08-30 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | SQUARE PHARMACEUTICALS LIMITED | 0f9b1fd8-a648-45c9-8655-14de07439f34 | 2023-07-02 | Aripiprazole ARIPIPRAZOLE | |
| Aripiprazole | ARIPIPRAZOLE | XLCare Pharmaceuticals, Inc. | 0a6fa113-6bb2-4f88-af07-ce0914c98ff2 | 2023-06-16 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | ScieGen Pharmaceuticals Inc | a7d9d5d1-25ba-4f4e-a990-398c0bf09c7e | 2023-02-20 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Alembic Pharmaceuticals Limited | 4f1691a8-724e-430d-9bab-27b59ef9bd4e | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Alembic Pharmaceuticals Limited | 793fc904-2f11-4f97-a0ac-4d6910cac0f9 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | XLCare Pharmaceuticals, Inc. | b284b294-40a0-4ccd-b7b7-b61267cd4e76 | 2023-01-16 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| ARIPIPRAZOLE | ARIPIPRAZOLE | A-S Medication Solutions | aaf7dc7e-04f3-442b-86d7-5f54d17d102c | 2022-09-12 | Boxed warning, Warnings, Adverse reactions | ARIPIPRAZOLE ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | NCS HealthCare of KY, LLC dba Vangard Labs | 8da99c93-613e-4b78-9f91-3efc2dea194d | 2022-08-02 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Proficient Rx LP | 19a3c2f2-11eb-4ec9-ac38-134168bdf99c | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Proficient Rx LP | 11202c0a-7401-41c9-b1e7-d93739fcd36f | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Dr.Reddys Laboratories Inc | 0aa7e178-456a-4942-93aa-9ec18a58939f | 2020-06-16 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | ScieGen Pharmaceuticals Inc | 95954ba3-e838-4dd7-aef1-c51ac6aff76b | 2020-05-06 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Proficient Rx LP | dbdc8fbe-c75f-4f17-a2cd-9f23802dcc5d | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Exelan Pharmaceuticals, Inc. | 705190bf-9f9d-4183-a56b-4eeafeacde59 | 2018-12-28 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81193 | ORIG | 2025-02-10 |